Safety and Tolerability of Nicotinamide Riboside in Heart Failure
The ChromaDex Research Communications Initiative is pleased to share a summary of a new study on Nicotinamide Riboside (NR) supplementation in Stage C heart failure patients. This study builds on the 2020 Zhou et al. study that showed that boosting Nicotinamide Adenine Dinucleotide (NAD+) with NR can improve peripheral blood mononuclear cell (PBMC) mitochondrial respiration and may … Read more